Clinical Trial: Generic Plerixafor Efficacy of Autologous Hematopoietic Stem Cell Transplantation

U.S., March 25 -- ClinicalTrials.gov registry received information related to the study (NCT06892119) titled 'Generic Plerixafor Efficacy of Autologous Hematopoietic Stem Cell Transplantation' on Dec. 09, 2019.

Brief Summary: Generic plerixafor use at reduced-dose for mobilization on HSCT transplant

Study Start Date: Dec. 09, 2019

Study Type: INTERVENTIONAL

Condition: Lymphoma Myeloma

Intervention: DRUG: Celrixafor

Use a reduced-dose of generic plerixafor

Recruitment Status: COMPLETED

Sponsor: Hospital Universitario Dr. Jose E. Gonzalez

Information provided by (Responsible Party): Cesar Homero Gutierrez-Aguirre, Hospital Universitario Dr. Jose E. Gonzalez

Published by HT Digital Content Services with permission from Health Daily...